Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001171843-14-005182
Filing Date
2014-11-03
Accepted
2014-11-03 16:58:04
Documents
3
Period of Report
2014-10-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT gff3_luppino110314.html 3  
1 OWNERSHIP DOCUMENT gff3_luppino110314.xml 3 1584
2 POWER OF ATTORNEY exh_241.htm EX-24.1 562
3 GRAPHIC luppino.jpg GRAPHIC 243631
  Complete submission text file 0001171843-14-005182.txt   339383
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Issuer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address
Business Address
LUPPINO FRANCESCO J (Reporting) CIK: 0001244295 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14027 | Film No.: 141190127